121 related articles for article (PubMed ID: 10928472)
1. Prevention of renal fibrin deposition in endotoxin-induced DIC through inhibition of PAI-1.
Montes R; Declerck PJ; Calvo A; Montes M; Hermida J; Muñoz MC; Rocha E
Thromb Haemost; 2000 Jul; 84(1):65-70. PubMed ID: 10928472
[TBL] [Abstract][Full Text] [Related]
2. Endotoxin-induced intravascular coagulation in rabbits: effect of tissue plasminogen activator vs urokinase of PAI generation, fibrin deposits and mortality.
Paloma MJ; Páramo JA; Rocha E
Thromb Haemost; 1995 Dec; 74(6):1578-82. PubMed ID: 8772240
[TBL] [Abstract][Full Text] [Related]
3. Effect of DDAVP on endotoxin-induced intravascular coagulation in rabbits.
Paloma MJ; Páramo JA; Rocha E
Thromb Haemost; 1992 Sep; 68(3):306-9. PubMed ID: 1440497
[TBL] [Abstract][Full Text] [Related]
4. Effect of heparin and/or antithrombin III on the generation of endotoxin-induced plasminogen activator inhibitor.
Gómez C; Páramo JA; Colucci M; Rocha E
Thromb Haemost; 1989 Sep; 62(2):694-8. PubMed ID: 2683190
[TBL] [Abstract][Full Text] [Related]
5. Effect of the administration of recombinant hirudin and/or tissue-plasminogen activator (t-PA) on endotoxin-induced disseminated intravascular coagulation model in rabbits.
Muñoz MC; Montes R; Hermida J; Orbe J; Páramo JA; Rocha E
Br J Haematol; 1999 Apr; 105(1):117-21. PubMed ID: 10233373
[TBL] [Abstract][Full Text] [Related]
6. The effect of fibrinolytic enzyme FIIa from Agkistrodon acutus venom on disseminated intravascular coagulation in rabbits.
Lin X; Liang XX; Chen JS; Chen Q; Qiu PX; Yan GM
Transl Res; 2007 Nov; 150(5):295-302. PubMed ID: 17964518
[TBL] [Abstract][Full Text] [Related]
7. The endotoxin-induced plasminogen activator inhibitor-1 increase in rabbits is not tumor necrosis factor-alpha dependent and can occur in the absence of interleukin-1beta.
Montes R; Rodríguez-Wilhelmi P; Hurtado V; Matsukawa A; Montes M; Hermida J; Rocha E
Thromb Haemost; 2002 Oct; 88(4):639-43. PubMed ID: 12362236
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment of curcumin attenuates coagulopathy and renal injury in LPS-induced endotoxemia.
Chen HW; Kuo HT; Chai CY; Ou JL; Yang RC
J Endotoxin Res; 2007; 13(1):15-23. PubMed ID: 17621542
[TBL] [Abstract][Full Text] [Related]
9. Pathophysiology of disseminated intravascular coagulation (DIC) progresses at a different rate in tissue factor-induced and lipopolysaccharide-induced DIC models in rats.
Asakura H; Suga Y; Yoshida T; Ontachi Y; Mizutani T; Kato M; Ito T; Morishita E; Yamazaki M; Miyamoto K; Nakao S
Blood Coagul Fibrinolysis; 2003 Apr; 14(3):221-8. PubMed ID: 12695743
[TBL] [Abstract][Full Text] [Related]
10. [Monoclonal antibody therapy for disorders of hemostasis and coagulation].
Nishimura S; Ishida T; Imai K
Nihon Rinsho; 2002 Mar; 60(3):525-30. PubMed ID: 11904968
[TBL] [Abstract][Full Text] [Related]
11. Endotoxin-induced disseminated intravascular coagulation in rabbits: effect of recombinant hirudin on hemostatic parameters, fibrin deposits, and mortality.
Hermida J; Montes R; Páramo JA; Rocha E
J Lab Clin Med; 1998 Jan; 131(1):77-83. PubMed ID: 9452130
[TBL] [Abstract][Full Text] [Related]
12. Effect of urinary protein C inhibitor on lipopolysaccharide-induced disseminated intravascular coagulation in rats.
Fujita M; Izutani W; Komurasaki Y
Thromb Haemost; 2000 Jul; 84(1):54-8. PubMed ID: 10928470
[TBL] [Abstract][Full Text] [Related]
13. Beneficial effect of the active form of vitamin D3 against LPS-induced DIC but not against tissue-factor-induced DIC in rat models.
Asakura H; Aoshima K; Suga Y; Yamazaki M; Morishita E; Saito M; Miyamoto K; Nakao S
Thromb Haemost; 2001 Feb; 85(2):287-90. PubMed ID: 11246549
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin preparations attenuate organ dysfunction and hemostatic abnormality by suppressing the production of cytokines in lipopolysaccharide-induced disseminated intravascular coagulation in rats.
Asakura H; Takahashi Y; Kubo A; Ontachi Y; Hayashi T; Omote M; Arahata M; Kadohira Y; Maekawa M; Yamazaki M; Morishita E; Takami A; Yoshida T; Miyamoto K; Nakao S
Crit Care Med; 2006 Sep; 34(9):2421-5. PubMed ID: 16810104
[TBL] [Abstract][Full Text] [Related]
15. Maximal PAI-1 inhibition in vivo requires neutralizing antibodies that recognize and inhibit glycosylated PAI-1.
Van De Craen B; Scroyen I; Vranckx C; Compernolle G; Lijnen HR; Declerck PJ; Gils A
Thromb Res; 2012 Apr; 129(4):e126-33. PubMed ID: 22178065
[TBL] [Abstract][Full Text] [Related]
16. Immunological quantitation of rabbit plasminogen activator inhibitor-1 in biological samples: evidence that rabbit platelets do not contain PAI-1.
Ngo TH; Declerck PJ
Thromb Haemost; 1999 Nov; 82(5):1510-5. PubMed ID: 10595646
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibody-based immunoassays for the specific quantitation of rat PAI-1 antigen and activity in biological samples.
Ngo TH; Verheyen S; Knockaert I; Declerck PJ
Thromb Haemost; 1998 Apr; 79(4):808-12. PubMed ID: 9569197
[TBL] [Abstract][Full Text] [Related]
18. Hemostatic markers and the sepsis-related organ failure assessment score in patients with disseminated intravascular coagulation in an intensive care unit.
Okabayashi K; Wada H; Ohta S; Shiku H; Nobori T; Maruyama K
Am J Hematol; 2004 Jul; 76(3):225-9. PubMed ID: 15224356
[TBL] [Abstract][Full Text] [Related]
19. Rapid in vivo induction of leukocyte tissue factor mRNA and protein synthesis following low dose endotoxin administration to rabbits.
Brutzki TC; Kulczycky MJ; Bardossy L; Clarke BJ; Blajchman MA
Hematol J; 2001; 2(3):188-95. PubMed ID: 11920244
[TBL] [Abstract][Full Text] [Related]
20. The activation of neutrophil elastase-mediated fibrinolysis is not sufficient to overcome the fibrinolytic shutdown of disseminated intravascular coagulation associated with systemic inflammation.
Gando S; Hayakawa M; Sawamura A; Hoshino H; Oshiro A; Kubota N; Jesmin S
Thromb Res; 2007; 121(1):67-73. PubMed ID: 17397908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]